Revenue (Tables)

3 Months Ended

Mar. 31, 2024

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregated Revenue

The following table presents our disaggregated revenue for the periods presented (in thousands):

	Three Months Ended March 31,
	2024		2023
MRD revenue
Service revenue	$	28,126	$	21,427
Regulatory milestone revenue		4,500		—
Total MRD revenue		32,626		21,427
Immune Medicine revenue
Service revenue		4,559		7,102
Collaboration revenue		4,688		9,118
Total Immune Medicine revenue		9,247		16,220
Total revenue	$	41,873	$	37,647